These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 944093)

  • 1. A characterization of the immunosuppressive activity of adriamycin and daunomycin on humoral antibody production and tumor allograft rejection.
    Vecchi A; Mantovani A; Tagliabue A; Spreafico F
    Cancer Res; 1976 Apr; 36(4):1222-7. PubMed ID: 944093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of adriamycin and daunomycin on antitumoral immune effector mechanisms in an allogeneic system.
    Mantovani A; Vecchi A; Tagliabue A; Spreafico F
    Eur J Cancer (1965); 1976 May; 12(5):371-9. PubMed ID: 954795
    [No Abstract]   [Full Text] [Related]  

  • 3. Steroid contraceptive agents and immunological reactivity in experimental animals.
    Vecchi A; Tagliabue A; Mantovani A; Anaclerio A; Barale C; Spreafico F
    Biomedicine; 1976; 24(4):231-7. PubMed ID: 1086685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo cytotoxicity of adriamycin and daunomycin for murine macrophages.
    Mantovani A
    Cancer Res; 1977 Mar; 37(3):815-20. PubMed ID: 837378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunodepressive and hematotoxic activities of N-trifluoro-acetyl-adriamycin-14-valerate.
    Vecchi A; Spreafico F; Sironi M; Cairo M; Garattini S
    Eur J Cancer (1965); 1980 Oct; 16(10):1289-96. PubMed ID: 7202463
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of host defense merchanisms in the antitumor activity of adriamycin and daunomycin in mice.
    Mantovani A; Polentarutti N; Luini W; Peri G; Spreafico F
    J Natl Cancer Inst; 1979 Jul; 63(1):61-6. PubMed ID: 286835
    [No Abstract]   [Full Text] [Related]  

  • 7. Synergism in immunosuppression. 3. Allograft rejection and humoral antibody production in intact and splenectomized mice.
    Gelfand MC; Nowakowski A; Friedman EA; Knepshield JH
    Transplantation; 1971 Nov; 12(5):377-83. PubMed ID: 4948689
    [No Abstract]   [Full Text] [Related]  

  • 8. T killer cells play a role in allogeneic bone marrow graft rejection but not in hybrid resistance.
    Dennert G; Anderson CG; Warner J
    J Immunol; 1985 Dec; 135(6):3729-34. PubMed ID: 3905963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dynamics of the immunodepressive and antitumor activity of adriamycin].
    Vereina TL; Turishchev VE; Gavrilova AD; Matveev AB
    Farmakol Toksikol; 1986; 49(1):73-5. PubMed ID: 3948992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunosuppressive properties of vinblastine and colchicine].
    Leont'eva TI; Maksimova GF; Babichev VA; Uteshev BS
    Tsitologiia; 1977 Feb; 19(2):186-91. PubMed ID: 18824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA breaks in P288 tumor cells in mice after treatment with daunorubicin and adriamycin.
    Schwartz HS
    Res Commun Chem Pathol Pharmacol; 1975 Jan; 10(1):51-64. PubMed ID: 1124321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTY720 inhibits TH1-mediated allogeneic humoral immune response.
    Peñuelas-Rivas G; Domínguez-Perles R; Brinkmann V; Del Rio ML; Muñoz-Luna A; Ramírez-Romero P; Parrilla-Paricio P; Rodríguez-Barbosa JI
    Transplant Proc; 2005 Nov; 37(9):4124-6. PubMed ID: 16386642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of adriamycin and daunomycin in L1210 and human leukemia cells: a comparative study.
    Chervinsky DS; Wang JJ
    J Med; 1976; 7(1):63-79. PubMed ID: 1064679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative characteristics of the antitumor and immunodepressive activity of carminomycin on the L-1210 experimental model].
    Berezina TA; Uteshev BS
    Antibiotiki; 1979 Oct; 24(10):767-71. PubMed ID: 496420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contrary action of khingamin on the rejection of a skin allograft and on the level of antibody-producing cells in mice].
    Gamburg LIu; Cheredeev AN
    Biull Eksp Biol Med; 1987 Jun; 103(6):727-30. PubMed ID: 3297194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective immunosuppression by drugs in balanced immune responses.
    Heppner GH; Griswold DE; Di Lorenzo J; Poplin EA; Calabresi P
    Fed Proc; 1974 Aug; 33(8):1882-5. PubMed ID: 4602113
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study of antineoplastic and immunosuppressive properties of ftorafur].
    Nosova TA; Babichev VA; Uteshev BS
    Farmakol Toksikol; 1976; 39(5):589-93. PubMed ID: 800767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of iodobenzoteph and cytostasan on several immune responses in animals].
    Pykhtina AA
    Farmakol Toksikol; 1978; 41(6):719-23. PubMed ID: 82518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of bone marrow allograft rejection and hybrid resistance in nonresponder recipients by antibody: is there evidence for a dual receptor interaction in acute marrow graft rejection?
    Dennert G; Anderson CG; Warner J
    J Immunol; 1986 Jun; 136(11):3981-6. PubMed ID: 3517162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The response of C3H mice to an L1210 tumor allograft.
    Nevalainen DE
    Res Commun Chem Pathol Pharmacol; 1974 Apr; 7(4):771-4. PubMed ID: 4828768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.